Myriad Genetics to Announce Financial Results for the Third Quarter of Fiscal Year 2014 on Tuesday, May 6, 2014
April 22 2014 - 4:05PM
Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will
issue financial results for the third fiscal quarter of 2014
following the close of market on Tuesday, May 6, 2014.
The Company also will host a conference call on Tuesday, May 6,
2014 at 4:30 p.m. ET to discuss the financial results.
Participating on the call will be Peter Meldrum, president and
chief executive officer; Mark Capone, president of Myriad Genetic
Laboratories, Inc.; and James Evans, chief financial officer.
To listen to the call, interested parties may dial 800-667-8757
in the United States or +1 303-223-4377 for international
callers. All callers will be asked to reference reservation
number 21714202.
The conference call also will be available through a live
webcast at www.myriad.com. A replay will be available two hours
after the end of the call and for the following seven days, and may
be accessed by dialing 800-633-8284 within the United States or +1
402-977-9140 for international callers and entering reservation
number 21714202.
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic company
dedicated to making a difference in patients' lives through the
discovery and commercialization of transformative tests to assess a
person's risk of developing disease, guide treatment decisions and
assess risk of disease progression and recurrence. Myriad's
molecular diagnostic tests are based on an understanding of the
role genes play in human disease and were developed with a
commitment to improving an individual's decision making process for
monitoring and treating disease. Myriad is focused on strategic
directives to introduce new products, including companion
diagnostics, as well as expanding internationally. For more
information on how Myriad is making a difference, please visit the
Company's website: www.myriad.com.
Myriad, the Myriad logo, Prolaris, Myriad myPath, Myriad myPlan,
and Myriad myRisk, are trademarks or registered trademarks of
Myriad Genetics, Inc. in the United States and foreign countries.
MYGN-F, MYGN-G.
CONTACT: Media Contact:
Ron Rogers
(801) 584-3065
rrogers@myriad.com
Investor Contact:
Scott Gleason
(801) 584-1143
sgleason@myriad.com
Myriad Genetics (NASDAQ:MYGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Myriad Genetics (NASDAQ:MYGN)
Historical Stock Chart
From Apr 2023 to Apr 2024